---
title: "HbA1c"
description: "HbA1c measures average blood sugar over 2–3 months and guides GLP-1 therapy decisions in Indian diabetes care."
canonical: "https://www.kesho.health/glossary/hba1c"
markdown_url: "https://www.kesho.health/md/glossary/hba1c"
language: "en-IN"
---

# HbA1c

**Canonical HTML:** https://www.kesho.health/glossary/hba1c  
**Markdown:** https://www.kesho.health/md/glossary/hba1c

## Definition

HbA1c (glycated haemoglobin) reflects average blood glucose over approximately three months, expressed as a percentage or mmol/mol.

## Extended

RSSDI typically targets HbA1c below 7–7.5% for most adults. GLP-1 RAs are added when HbA1c remains above target despite metformin and lifestyle. Monitored every 3–6 months on therapy. In India, these concepts appear in RSSDI and ICMR guidance for type 2 diabetes and obesity care—always confirm details with your prescribing physician.

## Learn more

[Full guide](https://www.kesho.health/blog/glp-1-and-other-diabetes-meds) · [MD](https://www.kesho.health/md/blog/glp-1-and-other-diabetes-meds)

## Related terms

- [type-2-diabetes](https://www.kesho.health/glossary/type-2-diabetes)
- [prediabetes](https://www.kesho.health/glossary/prediabetes)